biohaven: "rimegepant pivotal phase 3 trial results -- conference call."
.
.. he wasn't certain, though, how much he'd be able to work before then.
.
andrew kaye, head of policy at macmillan cancer support said it was �shocking� that a cancer patient had to wait 541 days for treatment. .